Nemes Rush Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$887 Hold
148
﹤0.01% 840
2025
Q4
$1.06K Hold
148
﹤0.01% 808
2025
Q3
$1.58K Sell
148
-19
-11% -$186 ﹤0.01% 610
2025
Q2
$1.62K Sell
167
-37
-18% -$382 ﹤0.01% 618
2025
Q1
$3.04K Sell
204
-69
-25% -$1.06K ﹤0.01% 578
2024
Q4
$4.08K Sell
273
-152
-36% -$2.48K ﹤0.01% 556
2024
Q3
$7.99K Hold
425
﹤0.01% 419
2024
Q2
$8.8K Hold
425
﹤0.01% 417
2024
Q1
$7.99K Hold
425
﹤0.01% 456
2023
Q4
$6.13K Sell
425
-4
-0.9% -$54 ﹤0.01% 471
2023
Q3
$7.45K Sell
429
-299
-41% -$6.24K ﹤0.01% 436
2023
Q2
$15.2K Buy
+728
New +$15.8K ﹤0.01% 387

Other funds holding OGN

Nemes Rush Group's OGN Position: Q1 2026 in Review

Nemes Rush Group held its Organon & Co (OGN) position steady in Q1 2026 at 148 shares worth $887. The position accounts for ﹤0.01% of the portfolio, ranked #840.

Nemes Rush Group first reported a position in OGN in Q2 2023 and has held it in 12 quarters since. The position peaked at $15.2K in Q2 2023. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Nemes Rush Group held 148 shares of Organon & Co worth $887 as of Q1 2026.
  • Nemes Rush Group left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Nemes Rush Group's portfolio in Q1 2026, its #840 holding.
  • Nemes Rush Group first reported a position in Organon & Co in Q2 2023 and has held it in 12 quarters since.
  • Nemes Rush Group's Organon & Co position peaked at $15.2K in Q2 2023.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.